Scrip
>>Focus On Asia
>>China

Despite China Weakness, Lilly Gung-Ho On Forteo, Humalog

03 Feb 2016

• By Ying Huang

Eli Lilly said in its Q4 earning call that slowdown in emerging markets would continue in the coming year, highlighting a tough year in China, with possible worse growth in the country depending on its on-going whole pricing policies. Though some brands will remain strong and accelerate growth, particularly Forteo.

SHANGHAI - Eli Lilly & Co. expects to see accelerated growth for a few key products in emerging markets, particularly in China, despite an overall drop in revenues in these markets last year.

It is critical that the company focus on brands that have significant growth opportunities, although the slowdown in emerging market...